HENGRUI PHARMA: Citigroup Inc. Disposes of Shares, Long Position Falls to 5.43%

HK Disclosure11-09

On November 3, 2026, Citigroup Inc. disposed of 1.55 million shares of HENGRUI PHARMA (H shares), reflecting a reduction in the shares held in its securities lending pool; this was not a direct secondary-market dealing, and the filing records an average price of HKD 0.0000 per share with disclosed consideration of HKD 0.

Prior to the disposal, Citigroup Inc.’s long position in HENGRUI PHARMA was 15.58 million shares, representing 6.03%; following the disposal, the holding changed to 14.03 million shares, with the long position ratio falling to 5.43%.

Source: Hong Kong Exchanges and Clearing Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment